Arcutis Biotherapeutics Inc (ARQT) Implied Volatility Current

Tracking ARQT implied volatility helps you identify when options premiums on Arcutis Biotherapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Arcutis Biotherapeutics Inc implied volatility reflects the market's expectation of future price movement: when ARQT IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Arcutis Biotherapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ARQT, tracking metrics like ARQT IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ARQT signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata.

The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ARQT implied volatility sits today versus where it has been. Our scanner ranks Arcutis Biotherapeutics Inc implied volatility against its historical range, surfaces extremes in ARQT IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Arcutis Biotherapeutics Inc IV is rich or cheap — measure it, then act on it.